截至发稿，朱明睿累计任职时间3年134天，现任基金资产总规模7907.3万元，任职期间最佳基金回报 25.32%， 任职期间最差基金回报-10.61%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 数据显示，诺德基金旗下1只基金重仓泽璟制药。诺德中小盘混合（570006）三季度持有股数1.6万股， 占基金净值比例为4.98%，位居第八大重仓股。根据测算，今日浮盈赚取约8.29万元。 诺德中小盘混合（570006）成立日期2010年6月28日，最新规模3628.58万。今年以来收益35.29%，同类 排名2236/8145；近一年收益20.64%，同类排名3426/8059；成立以来收益65.44%。 诺德中小盘混合（570006）基金经理为朱明睿。 11月13日，泽璟制药涨5.13%，截至发稿，报106.15元/股，成交2.98亿元，换手率1.09%，总市值280.99 亿元。 资料显示，苏州泽璟生物制药股份有限公司位于江苏省昆山市玉山镇晨丰路262号，成立日期200 ...

Group 1 - The core viewpoint of the news is that Yipinhong Pharmaceutical Group Co., Ltd. has shown a significant stock price increase of 5.23%, reaching 70.19 CNY per share, with a total market capitalization of 31.704 billion CNY [1] - Yipinhong's main business includes the research, production, and sales of its own pharmaceuticals, as well as the sales of agent pharmaceuticals, with revenue composition being 61.12% from children's medicine, 22.71% from chronic disease medicine, and 16.17% from other products [1] Group 2 - According to fund data, Nord Fund has a significant holding in Yipinhong, with the Nord Small and Mid-Cap Mixed Fund (570006) holding 27,000 shares, accounting for 4.49% of the fund's net value, ranking as the tenth largest holding [2] - The Nord Small and Mid-Cap Mixed Fund has achieved a year-to-date return of 52.57%, ranking 541 out of 8248 in its category, and a one-year return of 53.23%, ranking 2182 out of 8051 [2] Group 3 - The fund manager of the Nord Small and Mid-Cap Mixed Fund is Zhu Mingrui, who has been in the position for 3 years and 68 days, with the fund's total asset size being 70.9838 million CNY [3] - During Zhu Mingrui's tenure, the best fund return was 43.58%, while the worst return was -6.35% [3]